4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies - Wikidata - awgldk - TriplyDB

4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies

4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies

http://www.wikidata.org/entity/Q33819935

about

CAR models: next-generation CAR modifications for enhanced T-cell function Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy Novel immunotherapies in lymphoid malignancies Lymphoma Immunotherapy: Current Status CAR T Cell Therapy: A Game Changer in Cancer Treatment Developing strategies in the immunotherapy of leukemias Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies.Engineered T cells for cancer treatment Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice.FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance The basic principles of chimeric antigen receptor design.4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells.Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer.Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments.miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies Synthetic biology for therapeutic applications.IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells How do CARs work?: Early insights from recent clinical studies targeting CD19.Cellular therapies in acute lymphoblastic leukemia An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma.Antibody-based therapeutics for the treatment of human B cell malignancies Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood trans Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia: Two case reports.IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia.Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.Genetic redirection of T cells for cancer therapy.Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors.Adoptive immunotherapy for cancer.CAR T cells: driving the road from the laboratory to the clinic.Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.

P2860

Q26745600-F9E7B636-C5C3-4BB5-8A7A-EA9ECF37788A Q26773309-CD6EA0B6-D617-4064-8CB7-B117E27BC468 Q26777394-6F724103-0C5F-43E5-A515-3276DC50FB38 Q26782902-CD055EA8-BC76-445B-8B04-EE13E0F1FD2B Q26822769-0394F8FA-F1CC-4224-A078-8154C5F5BE1F Q26996310-A1A85A05-02F7-494B-99F1-F6043AF12970 Q27025300-659DF8DF-4674-44B4-9FFE-8ABFBB8EE8AF Q28081600-D3717A2E-D37F-4BB7-A453-2F321130F221 Q33426409-55EE18CD-E1FB-4C82-8A59-D942F520BCFF Q33578792-D9A349BF-6F3F-47C5-840B-119495E94DE8 Q33603041-1E05F7E1-E078-4A1F-912D-6CB5BBE97D91 Q33607015-7C918B86-6D60-4D8D-9D71-3A5DAEE0BC8E Q34036213-0D4499C6-80BE-4424-A7D8-97DAE422BE63 Q34180031-A8FD19C2-E574-45C6-8381-EEB62CCB330B Q34240799-E5BB516E-5D9A-4E57-A22B-21A687B7289F Q34550649-656F7D7C-0501-4A5C-9442-AF98A5DBE40A Q34729692-F2C5CF14-34D7-4360-9D8B-261C467BE235 Q34923649-BEBBD7D4-38EB-473C-8525-48C954EE982D Q34923751-F7935875-5399-4381-9602-682AE6AB9068 Q34923799-928A58ED-E48B-480B-8B2A-A20A1911F18A Q35057524-CCD4599C-4969-4EF1-824E-14BEEE394E83 Q35690979-0B71E6E5-9E48-4888-BBF0-2BD59F1DEB1C Q35877585-4FAFEDD8-BFD0-413B-9909-19BA9DADEE26 Q35980893-F0166378-7958-4C79-818B-110C75C92FF9 Q36413053-6FFD1D19-9D36-43ED-8082-077DDFD1D531 Q36470354-A937AD10-E20A-4AD9-A4AA-71715266B791 Q36476104-6A9831AD-9A8C-4ACF-A655-9D8BB86B7391 Q36552098-BF754BE9-7F70-4728-9624-12125471123A Q36787587-516CA6BC-CA2C-4279-957E-985CC12F47AC Q36858767-97725674-38BF-4463-8DF2-23621F3FA5AF Q36907540-9D55A768-CAD8-48C8-864E-ACF4A76A8427 Q37339212-093694B1-7D79-4853-A91E-4ED7AD2037CA Q37530579-FBB60C7C-87F6-456E-BD93-B0B629956979 Q37536195-38AE749C-8BE0-4361-8A41-219DBED6E495 Q37592957-5B3B9AB2-2F9D-4AE8-B004-2801968C938A Q37697337-F08F8E86-0D62-46FD-ABD7-F3D3A97593E4 Q38096411-D607085E-F6F1-4432-B454-1BF7081D518F Q38170496-F608A99C-8266-44A7-9318-A87B3D6267C2 Q38170499-7345DE68-0C96-4771-98F9-F926F026E999 Q38400420-26128DE2-0178-447F-9352-CE5082BEC9FC

P2860

4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies

http://www.wikidata.org/entity/Q33819935

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@ast

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@en

type

label

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@ast

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@en

prefLabel

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@ast

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@en

P1433

Q33819935-908732FD-B156-4224-8667-685C2B8D224B

P1476

Q33819935-AD80E62F-CE90-4A36-B5CF-79630460BF78

P2093

Q33819935-0E475B91-A58A-45BF-A314-9959AA967C1D

Q33819935-15DAB907-4DC6-449D-A425-1D4EB518ADBF

Q33819935-316877EB-EE95-45AF-8593-F111EE1789DB

Q33819935-5B3F8CC7-82C6-4E05-970B-B0C466AFDA6C

Q33819935-7D549C44-E56D-4014-A3E8-C554E8F0B33D

Q33819935-7F4788F8-7080-4C70-BD1C-AF3148A46205

Q33819935-A1BD323B-9D7B-4E9D-972A-FFC61BD5D2C9

Q33819935-B1FF1722-F0FD-4F3D-8A99-F2CA844290C7

Q33819935-C8955828-6A44-45A6-9B7E-802CE029CC93

P2860

Q33819935-05D27DAA-6749-4EED-B750-A5BCBA6404A2

Q33819935-0F9CEE6D-ED0E-4D34-A0AB-25AE40A226A4

Q33819935-135F1419-89B7-48F1-8E03-0C299185D07E

Q33819935-1C411C58-B049-4B85-B159-A424BE5A4D89

Q33819935-1FFDCAE7-EFE1-456D-B1BD-94D0C1863220

Q33819935-23A6ED41-D79B-4B0A-A389-37F37237E792

Q33819935-353D7EE1-D59A-4801-ABF1-5D16D56EB680

Q33819935-3EB40404-5B92-479A-BC3B-D15DF6D41CFF

Q33819935-3F2E17DC-0A46-4A0D-B768-760D749D3D52

Q33819935-42FD193B-E120-4DB2-9855-AB1B28CBF29B

P304

Q33819935-A3FEAE73-726A-4E3D-857A-E38710347BE8

P31

Q33819935-69714F8C-BB80-4DB7-8300-606414D0B89E

P356

Q33819935-0D371F56-9080-4395-A8D8-E7953DAE35A8

P433

Q33819935-F86B0D47-8DF0-4314-AA40-D8BA9CA6E08F

P478

Q33819935-1A6B440F-1456-4B4A-B8BC-EEF67E6B0910

P50

Q33819935-6927E654-DDA1-48C2-8EA0-36EC5929C406

P577

Q33819935-193A3C41-82FB-4423-91A7-E09B14898A98

P5875

Q33819935-12D97954-2B8B-44B1-98C3-AFC458118307

P698

Q33819935-785CF845-F222-497B-8226-D844DF640952

P932

Q33819935-35B66E53-9B30-48D5-83EB-33D9C774E3E3

P356

P1433

Human Gene Therapy

P1476

4-1BB and CD28 signaling plays ...... ls against B-cell malignancies

@en

P2093

Bruce L Levine

http://www.w3.org/2001/XMLSchema#string

Carl H June

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

Linan Ma

http://www.w3.org/2001/XMLSchema#string

Marianna Wong

http://www.w3.org/2001/XMLSchema#string

Michael C Milone

http://www.w3.org/2001/XMLSchema#string

Syam Tammana

http://www.w3.org/2001/XMLSchema#string

Xianzheng Zhou

http://www.w3.org/2001/XMLSchema#string

Xin Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

TNF/TNFR family members in costimulation of T cell responses

Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28

Central memory and effector memory T cell subsets: function, generation, and maintenance

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production.

Deficient cellular immunity--finding and fixing the defects.

Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells.

Targeting tumours with genetically enhanced T lymphocytes.

Umbilical-cord blood transplantation for the treatment of cancer.

P304

75-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2009.122

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26779129

http://www.w3.org/2001/XMLSchema#string

P698

19719389

http://www.w3.org/2001/XMLSchema#string

P932

2861957

http://www.w3.org/2001/XMLSchema#string